Cargando…
Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery
The global pandemic of COVID-19 is a serious public health concern. Over 625 million confirmed cases and more than 6 million deaths have been recorded worldwide. Although several vaccines and antiviral medications have been developed, their efficacy is limited by the emerging new SARS-CoV-2 strains....
Autores principales: | Essa, Raahilah Zahir, Wu, Yuan-seng, Batumalaie, Kalaivani, Sekar, Mahendran, Poh, Chit-laa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676828/ https://www.ncbi.nlm.nih.gov/pubmed/36401119 http://dx.doi.org/10.1007/s43440-022-00432-6 |
Ejemplares similares
-
Antivirals blocking entry of enteroviruses and therapeutic potential
por: Anasir, Mohd Ishtiaq, et al.
Publicado: (2021) -
Molecular Mechanisms of Antiviral Agents against Dengue Virus
por: Lee, Michelle Felicia, et al.
Publicado: (2023) -
Antiviral peptides against Enterovirus A71 causing hand, foot and mouth disease
por: Lalani, Salima, et al.
Publicado: (2021) -
Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71)
por: Lalani, Salima, et al.
Publicado: (2020) -
Antiviral activity of silymarin in comparison with baicalein against EV-A71
por: Lalani, Salima S., et al.
Publicado: (2020)